The potential efficacy and mechanism of bendamustine in entra‐nodal NK/T cell lymphoma
Yuyang Gao(Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Zhaoming Li(First Affiliated Hospital of Zhengzhou University), Mengyuan Jin(First Affiliated Hospital of Zhengzhou University), Xiaoyan Feng(Academy of Military Medical Sciences), Lei Zhang(First Affiliated Hospital of Zhengzhou University), Hongwen Li(Anhui Medical University), Wenting Song(Huazhong Agricultural University), Cunzhen Shi(First Affiliated Hospital of Zhengzhou University)
Cited by 5
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|134